본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

골관절염환자에 있어서 경피투여후 피록시캄의 조직분포
Disposition of Piroxicam Following Transdermal Administration in Patients with Osteoarthritis

정원희    (삼성서울병원   ); 김명민    (삼성생명과학연구소   ); 윤경호    (삼성서울병원   ); 하권익    (삼성서울병원,성균관대학교 의과대학   ); 민동선    (선경인더스트리   ); 최경업    (삼성서울병원,삼성생명과학연구소  );
  • 초록

    Background : Piroxicam(P) is usually administered once or twice a day for the treatment of arthritis. Since arthritis is a chronic disease, patients require a long term therapy with P, which results in a number of side effects such as gastrointestinal disorders and bleeding. In order to lessen these side effects and to increase patient's compliance, the P transdermal patch has been developed. The purpose of this study was to compare the disposition of transdermal P with that of oral P at steady state. Methods : A total of twenty patients (4 males and 16 females) aged 54 to 77 years with osteoarthritis were randomized and equally divided into 2 group. Group I was treated with $Trast^{TM}$ transdermal patch containing 48mg of P (manufactured by Sunkyong Pharm., Seoul) on the knee every other day for 14 days, and Group II received oral P 20mg once a day for 14 days. We collected plasma and tissue samples from Group I at 36 hrs after the last application of transdermal patch and from Group II at 12 hrs following the last oral dose. P Concentrations in plasma and tissues were analyzed by high-performance liquid chromatography(HPLC) with UV detection. Wilcoxon rank sum test was performed to evaluate the differences between the two formulations. Results : P concentration in plasma following transdermal administration was significantly lower compared to that of oral administration $(0.11{\pm}0.19\;vs.\;5.69{\pm}2.26{\mu}g/ml,\;p . However, there was no statistical difference in the synovial fluid between Group I and Group II $(5.44{\pm}0.36\;vs.\;5.37{\pm}3.72{\mu}g/ml,\;p=0.2483)$ , while the inter-individual differences were lesser in Group I than in Group II (coefficient variation ; 6.6% vs. 69.3%). When compared to Group II, P concentrations In Group I were significantly lower in synovium, muscle, and adipose tissue $(0.0101{\pm}0.0148\;vs.\;0.0740{\pm}0.0249,0.0036{\pm}0.0021\;vs.\;0.0552{\pm}0.0341,and\;0.0034{\pm}0.0019\;vs.\;0.0256{\pm}0.0118{\mu}g/g;p Conclusion : The plasma concentration in Group I was 50 times lower than that in Group II, but the synovial fluid concentration was comparable, suggesting that the transdermal patch would be expected to produce equivalent therapeutic effects and reduce systemic side effects.


  • 주제어

    Piroxicam .   Transdermal patrh .   Plasma concentration .   Synovial fluid .   HPLC.  

 저자의 다른 논문

 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역

원문보기

무료다운로드
  • 대한임상약리학회 : 저널
유료다운로드
  • 원문이 없습니다.

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 출판된 논문 + 더보기